Mineralys Therapeutics, Inc.MLYSNASDAQ

Revenue (LTM)

Net Income (LTM)

$-155M

+13.0% YoY

Free Cash Flow

$-142M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-19	-31↓68.1%	-85↓168.9%	-192↓127.3%	-171↑11.3%
Net Income	-19	-30↓53.5%	-72↓141.3%	-178↓147.3%	-155↑13.0%
EBITDA	-19	-31↓62.4%	-85↓168.9%	-192↓127.2%	-171↑11.3%
EPS Diluted	-3.89	-5.77↓48.3%	-1.99↑65.5%	-3.66↓83.9%	-2.29↑37.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	11	88↑726.4%	49↓43.8%	114↑131.4%	173↑51.6%
Total Current Assets	11	113↑914.3%	249↑120.8%	205↓17.6%	661↑222.1%
Total Assets	11	114↑928.7%	252↑119.9%	206↓18.2%	662↑221.4%
Total Current Liabilities	5	8↑59.6%	10↑29.9%	15↑39.7%	15↑3.2%
Total Liabilities	34	167↑389.6%	10↓93.7%	15↑39.7%	15↑3.2%
Total Equity	-23	-52↓128.0%	241↑561.4%	191↓20.7%	647↑238.1%
Total Debt	0	0	0	0	0
Net Debt	-11	-88↓726.4%	-49↑43.8%	-114↓131.4%	-173↓51.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-15	-29↓100.7%	-81↓177.8%	-166↓104.9%	-142↑14.4%
Capital Expenditure	0	0	0	-0	-0↑84.4%
Free Cash Flow	-15	-29↓100.7%	-81↓177.8%	-166↓105.0%	-142↑14.4%
Stock-Based Comp	0	0↑468.8%	5↑1012.1%	11↑124.0%	19↑70.5%
Net Change in Cash	9	77↑732.6%	-38↓149.8%	65↑268.7%	59↓9.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance